{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:00:45Z","timestamp":1770350445181,"version":"3.49.0"},"reference-count":33,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2022,6,12]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>We aimed to study the association between tramadol prescribed at discharge (after elective total hip and knee arthroplasty (THA\/TKA) surgery) and chronic opioid use postoperatively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study queried the Truven MarketScan database and identified patients who underwent an elective THA\/TKA surgery between 2016 and 2018 and were prescribed opioids at discharge (n=81 049). Multivariable analysis was conducted to study the association between tramadol prescription at discharge and chronic opioid use, with additional analysis adjusting for the amount of opioids prescribed in oral morphine equivalents. Chronic opioid use was defined as filling \u226510 opioid prescriptions or prescriptions for \u2265120 pills within the period from 90 days to 1 year after surgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, tramadol was prescribed at discharge in 11.0% of all THA\/TKA cases. Of those, 26.9% and 73.1% received tramadol only or tramadol with another opioid, respectively. Chronic opioid use was observed in 5.4% of cases. After adjustment for relevant covariates, prescription of tramadol combined with another opioid at discharge was associated with lower odds of chronic opioid use comparing to prescription of other opioids (OR 0.69 CI 0.61 to 0.78).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Among patients undergoing elective THA\/TKA surgery and discharged with a prescription of opioids, we found that prescription of tramadol combined with another opioid was associated with lower odds of chronic opioid use. This finding must be considered in the context of the tramadol\u2019s pharmacology, as well-described genetic differences in metabolism that can make it ineffective in many patients, while for patients with ultrarapid metabolism can cause drug\u2013drug interactions and adverse events, including feelings of high and seizures.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rapm-2022-103486","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T13:27:07Z","timestamp":1656336427000},"page":"560-565","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty"],"prefix":"10.1136","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-9398","authenticated-orcid":false,"given":"Sara","family":"Kiani","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-5102","authenticated-orcid":false,"given":"Jashvant","family":"Poeran","sequence":"additional","affiliation":[{"name":"Departments of Orthopedics \/ Population Health Science & Policy \/ Medicine, Icahn School of Medicine at Mount Sinai, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros","family":"Poultsides","sequence":"additional","affiliation":[{"name":"Academic Orthopedic Department, Aristotle University Medical School, General Hospital Papageorgiou, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-2786","authenticated-orcid":false,"given":"Jiabin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-0030","authenticated-orcid":false,"given":"Stavros G","family":"Memtsoudis","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"2025101109563607000_47.9.560.1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(19)30428-3","article-title":"Inappropriate opioid prescription after surgery","volume":"393","author":"Neuman","year":"2019","journal-title":"Lancet"},{"key":"2025101109563607000_47.9.560.2","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.arth.2017.03.014","article-title":"Opioid use after total knee arthroplasty: trends and risk factors for prolonged use","volume":"32","author":"Bedard","year":"2017","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.arth.2017.09.001","article-title":"Persistent opioid use following total knee arthroplasty: a signal for close surveillance","volume":"33","author":"Namba","year":"2018","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.4","first-page":"85","article-title":"Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty","volume":"33","author":"Skinner","year":"2004","journal-title":"Am J Orthop"},{"key":"2025101109563607000_47.9.560.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2013.06.005"},{"key":"2025101109563607000_47.9.560.6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF03012579","article-title":"Comparison of tramadol and morphine via subcutaneous PCA following major orthopaedic surgery","volume":"45","author":"Hopkins","year":"1998","journal-title":"Can J Anaesth"},{"key":"2025101109563607000_47.9.560.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2003.12.038"},{"key":"2025101109563607000_47.9.560.8","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1833"},{"key":"2025101109563607000_47.9.560.9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1213\/ANE.0000000000001943","article-title":"Lack of association between the use of nerve blockade and the risk of postoperative chronic opioid use among patients undergoing total knee arthroplasty: evidence from the Marketscan database","volume":"125","author":"Sun","year":"2017","journal-title":"Anesth Analg"},{"key":"2025101109563607000_47.9.560.10","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000003467"},{"key":"2025101109563607000_47.9.560.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2025101109563607000_47.9.560.12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.arth.2020.01.055","article-title":"Opioid use after total knee arthroplasty: does tramadol have lower risk than traditional opioids?","volume":"35","author":"DeMik","year":"2020","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.urology.2021.07.018","article-title":"Persistent opioid usage after urologic intervention and the impact of tramadol","volume":"157","author":"Wackerbarth","year":"2021","journal-title":"Urology"},{"key":"2025101109563607000_47.9.560.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1849"},{"key":"2025101109563607000_47.9.560.15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bja.2020.12.046","article-title":"Association between sex and perioperative opioid prescribing for total joint arthroplasty: a retrospective population-based study","volume":"126","author":"Soffin","year":"2021","journal-title":"Br J Anaesth"},{"key":"2025101109563607000_47.9.560.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1251"},{"key":"2025101109563607000_47.9.560.17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/papr.12789","article-title":"Trends of opioid use disorder among hospitalized patients with chronic pain","volume":"19","author":"Orhurhu","year":"2019","journal-title":"Pain Pract"},{"key":"2025101109563607000_47.9.560.18","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.arth.2020.04.093","article-title":"Preoperative pain management: is tramadol a safe alternative to traditional opioids before total hip arthroplasty?","volume":"35","author":"Bell","year":"2020","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.19","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.arth.2018.01.004","article-title":"Patients at Risk: Preoperative Opioid Use Affects Opioid Prescribing, Refills, and Outcomes After Total Knee Arthroplasty","volume":"33","author":"Hernandez","year":"2018","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.20","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000516"},{"key":"2025101109563607000_47.9.560.21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamasurg.2018.2102","article-title":"Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgery","volume":"153","author":"Hilliard","year":"2018","journal-title":"JAMA Surg"},{"key":"2025101109563607000_47.9.560.22","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.arth.2020.06.040","article-title":"Risk factors for chronic opioid use following hip and knee arthroplasty: evidence from New Zealand population data","volume":"35","author":"Pryymachenko","year":"2020","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0899"},{"key":"2025101109563607000_47.9.560.24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.arth.2022.01.072","article-title":"Does in-hospital opioid use affect opioid consumption after total joint arthroplasty?","volume":"37","author":"O'Brien","year":"2022","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpain.2016.06.007"},{"key":"2025101109563607000_47.9.560.26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.artd.2020.07.013","article-title":"Combating the opioid epidemic: experience with a single prescription for total joint arthroplasty","volume":"6","author":"Sun","year":"2020","journal-title":"Arthroplast Today"},{"key":"2025101109563607000_47.9.560.27","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.arth.2019.02.022","article-title":"Restrictive opioid prescribing protocols following total hip arthroplasty and total knee arthroplasty are safe and effective","volume":"34","author":"Holte","year":"2019","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/CORR.0000000000001390","article-title":"Opioid use disorder is associated with an increased risk of infection after total joint arthroplasty: a large database study","volume":"478","author":"Sodhi","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"2025101109563607000_47.9.560.29","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.arth.2018.05.027","article-title":"Preoperative opioids increase the risk of periprosthetic joint infection after total joint arthroplasty","volume":"33","author":"Bell","year":"2018","journal-title":"J Arthroplasty"},{"key":"2025101109563607000_47.9.560.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-019-2619-8","article-title":"Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis","volume":"20","author":"Goplen","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"2025101109563607000_47.9.560.31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.12.085","article-title":"An overview of tramadol and its usage in pain management and future perspective","volume":"111","author":"Subedi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2025101109563607000_47.9.560.32","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"Edinoff","year":"2021","journal-title":"Anesth Pain Med"},{"key":"2025101109563607000_47.9.560.33","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2022-103486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T16:56:45Z","timestamp":1760201805000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2022-103486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/rapm-2022-103486"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2022-103486","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]}}}